Navigation Links
Mylan Receives Approval for Generic Version of MS Contin® Tablets
Date:10/27/2011

PITTSBURGH, Oct. 27, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Morphine Sulfate Extended-release (ER) Tablets, 15 mg, 30 mg, 60 mg, 100 mg and 200 mg, the generic version of Purdue Pharma's MS Contin®, an opioid analgesic for moderate to severe pain management.  

Morphine Sulfate ER Tablets had U.S. sales of approximately $173 million for the 12 months ending June 30, 2011, according to IMS Health. Mylan is launching this product immediately.

Currently, Mylan has 163 ANDAs pending FDA approval representing $97.5 billion in annual sales, according to IMS Health. Forty-four of these pending ANDAs are potential first-to-file opportunities, representing $26.9 billion in annual brand sales, for the 12 months ending June 30, 2011, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
2. Mylans Dey Pharma Successfully Obtains Patent Reexamination Certificates for Two Perforomist® Patents
3. Matrix Laboratories Completes Name Change to Mylan Laboratories
4. Mylan Announces Femcon® Fe Settlement Agreement
5. Mylan Announces Intention to Refinance Existing Secured Credit Facility
6. Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar
7. Mylan Applauds Study Highlighting $931 Billion in Savings for U.S. Health Care System Due to Generic Drugs
8. Mylan Announces XELODA® Settlement and License Agreement
9. Mylans Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment
10. Mylan Launches Generic Version of Uroxatral® Tablets
11. Mylan Announces U.S. PTO Intends to Reissue Two Perforomist® Patents to Dey Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)...  Instrumentation Laboratory (IL) today announced the launch of its ... is part of a comprehensive rebranding effort by Werfen, the ... Boston, MA , in 1959, IL has been part ... companies in the group include Inova Diagnostics ( San ... Spain ).  Like IL, these three companies are focused ...
(Date:7/29/2014)... WESTFORD, Mass., July 29, 2014 Cynosure, ... and markets laser- and light-based aesthetic treatment systems for ... months ended June 30, 2014. Second-quarter 2014 financial results ... completed on June 24, 2013. ... revenues increased 45% to $72.6 million , Non-GAAP ...
(Date:7/29/2014)... 2014  Ambit Biosciences (Nasdaq: AMBI ), a ... targeting unmet needs in oncology, autoimmune and inflammatory disease, ... after closing of the NASDAQ Global Market on Tuesday, ... hosted by Michael Martino , president and CEO, ... on the same day at 5:00 pm EDT (2:00 ...
Breaking Medicine Technology:Instrumentation Laboratory Unveils New Corporate Brand 2Instrumentation Laboratory Unveils New Corporate Brand 3Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12Ambit Biosciences To Announce Second Quarter 2014 Financial Results 2
... The New England Journal of Medicine today released a study entitled, ... discussed in the report were brought by Phillips & Cohen LLP, a law ... Phillips & Cohen has specialized in representing whistleblowers for more than 20 years. ... Comments from Erika ...
... , May 12 The U.S. Food and Drug Administration is ... Itch Stopping Gel, an over-the-counter (OTC) product that should only be used on ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ... The FDA has received reports ...
Cached Medicine Technology:Whistleblower Lawyers Comment on New England Journal of Medicine Study 2Whistleblower Lawyers Comment on New England Journal of Medicine Study 3FDA: Serious Side Effects from Swallowing Topical Benadryl Product 2FDA: Serious Side Effects from Swallowing Topical Benadryl Product 3
(Date:7/29/2014)... Merrick, NY (PRWEB) July 29, 2014 Summer is ... whether that means enjoying a hike, swimming in a pool or ... it’s time for fleas and ticks. The Puppy Store is here ... during the summer months. , It’s almost impossible to completely keep ... can take to minimize the chances of their pets coming into ...
(Date:7/29/2014)... 29, 2014 A team of scientists, ... Ethell, PhD, has developed a blood test for Alzheimer’s ... the development of Alzheimer’s disease interventions, according to an ... a puzzle, and this study represents one of several ... the past couple of years,” Ethell said. , The ...
(Date:7/29/2014)... best way to cure most cases of cancer is ... this approach, however, is that the surgeon may fail ... recurrence. , With a new technique, researchers at the ... help surgeons see the entire tumor in the patient, ... relies on an injectable dye that accumulates in cancerous ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 As testosterone ... U.S. courts, Bernstein Liebhard LLP notes that a new ... men with Type 2 diabetes. The research, which was ... Metabolism on June 30th, involved 88 men who suffered ... to moderate aging male symptoms and erectile dysfunction. Roughly ...
(Date:7/29/2014)... America (GSA) and the National Center for Creative ... Columbia University as the 2014 recipient of the Gene ... This award recognizes and honors the seminal work of ... creativity and aging shifted the conceptual focus from a ... inspired individuals to approach longevity asking what wonders can ...
Breaking Medicine News(10 mins):Health News:Protect Dogs From Fleas and Ticks During the Summer 2Health News:Professor Develops Blood Test for Alzheimer’s Disease Risk 2Health News:Penn team makes cancer glow to improve surgical outcomes 2Health News:Penn team makes cancer glow to improve surgical outcomes 3Health News:As Testosterone Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Questioning Effectiveness of Low Testosterone Therapy in Diabetics 2Health News:As Testosterone Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Questioning Effectiveness of Low Testosterone Therapy in Diabetics 3Health News:As Testosterone Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Questioning Effectiveness of Low Testosterone Therapy in Diabetics 4Health News:Charon to receive 2014 Gene D. Cohen Award 2
... (Nasdaq: NUTR ) today reported results for the ... sales for the fiscal 2009 first quarter were $39.6 million ... 2008. For the first quarter of fiscal 2009, net ... compared to net income of $3.2 million, or $0.28 diluted ...
... MOUNTAIN VIEW, Calif., Jan. 29 Concentric Medical, ... removal in ischemic stroke patients, today announced the ... of the Outreach(TM) Distal Access Catheter for use ... Catheter provides neurointerventionalists additional access and support options ...
... growing list of Ancient Minerals international distributors. , ... ... Inc. announced today that Australian company Rejuve Health Products Pty Ltd. ... of Ancient Minerals topical magnesium products. Located in Buderim, Queensland, the ...
... the National Association of Medicaid Fraud Control Units ... has joined the Whistleblower Action Network through his ... Carson City, Nevada. The Whistleblower Action Network ... citizens, known as "relators," who witness fraud against ...
... France, January 29 , - A New Year ... Excluding the Currency Effect, - Higher Earnings Expected ... ophthalmic optics, today,announced consolidated revenue of EUR3,074.5 million for the year ... Excluding the currency effect, growth for the year was a strong ...
... Researchers from Boston University School of Medicine (BUSM) and ... have found that children born more than three months premature, ... the modified checklist for autism in toddlers (M-CHAT). Children ... for developing autism. These findings appear in the January ...
Cached Medicine News:Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 2Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 3Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 4Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 5Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 6Health News:Nutraceutical Reports Fiscal 2009 Q1 Results 7Health News:Concentric Medical Expands Product Offering in Neuro Access 2Health News:The Healing Power of Ancient Minerals Magnesium Oil Now Available Down Under 2Health News:Nationally Recognized Medicaid Fraud Prosecutor Tim Terry Joins Successful Whistleblower Law Practice, Specializing in "Qui Tam" Citizen Suits Under False Claims Acts 2Health News:Nationally Recognized Medicaid Fraud Prosecutor Tim Terry Joins Successful Whistleblower Law Practice, Specializing in "Qui Tam" Citizen Suits Under False Claims Acts 3Health News:Nationally Recognized Medicaid Fraud Prosecutor Tim Terry Joins Successful Whistleblower Law Practice, Specializing in "Qui Tam" Citizen Suits Under False Claims Acts 4Health News:Essilor : 2008 Revenue 2Health News:Essilor : 2008 Revenue 3Health News:Essilor : 2008 Revenue 4Health News:Essilor : 2008 Revenue 5Health News:Essilor : 2008 Revenue 6Health News:Study finds preemies more likely to score positive 2
... ENDOPATH EZ45 Endoscopic Linear Cutter has application ... surgical procedures for transection, resection, and/or creation ... staple line or tissue buttressing materials such ... reloaded seven times for a total of ...
... Linear Cutters provide a 45mm staple and ... the device suitable for many minimally invasive ... transection, resection, and/or creation of anastomoses in ... ,The LONG45A Endocutter has a shaft ...
ACUCLIP Endoscopic Right-Angle Multiple Clip Applier, 10 mm Shaft Diameter with 20, 8 mm Titanium Clips...
Insert only, Pilling-Weck medium clip size...
Medicine Products: